Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
632.90
+12.76 (2.06%)
At close: Jun 26, 2026, 4:00 PM EDT
631.38
-1.52 (-0.24%)
After-hours: Jun 26, 2026, 7:57 PM EDT

Regeneron Pharmaceuticals Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Collaboration
7.70B 7.33B 6.97B 6.66B 6.32B 6.06B 5.82B 5.60B
Collaboration Growth
21.77% 21.02% 19.69% 18.93% 17.26% 10.08% 1.76% 4.99%
Net Product
6.43B 6.31B 6.64B 7.00B 7.28B 7.63B 7.48B 7.32B
Net Product Growth
-11.73% -17.30% -11.24% -4.40% 1.57% 7.79% 7.98% 5.43%
Other
790.90M 701.80M 643.20M 559.40M 480.00M 515.00M 548.10M 572.20M
Other Growth
64.77% 36.27% 17.35% -2.24% -10.61% -3.94% 21.45% 44.06%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.